Zhongzhi Pharmaceutical Holdings Dirección
Dirección controles de criterios 4/4
Zhongzhi Pharmaceutical Holdings' El consejero delegado es Ying Feng Lai , nombrado en Mar 2021, tiene un mandato de 2.92 años. la remuneración anual total es CN¥1.08M , compuesta por 74.2% salario y 25.8% primas, incluidas acciones y opciones de la empresa. posee directamente 0.69% de las acciones de la empresa, por valor de HK$7.85M . La antigüedad media del equipo directivo y del consejo de administración es de 2.9 años y 8.7 años respectivamente.
Información clave
Ying Feng Lai
Chief Executive Officer (CEO)
CN¥1.1m
Compensación total
| Porcentaje del salario del CEO | 74.2% |
| Permanencia del CEO | 3.1yrs |
| Participación del CEO | 0.7% |
| Permanencia media de la dirección | 3.1yrs |
| Promedio de permanencia en la Junta Directiva | 8.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares
Feb 01
These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
May 24Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?
Aug 26Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet
Apr 28These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
Jun 11Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)
May 06Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues
Apr 21Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?
Mar 29The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More
Mar 05Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?
Feb 15
What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?
Jan 14Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?
Dec 27If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late
Dec 14Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?
Nov 30Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nov 17Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | CN¥163m |
| Sep 30 2023 | n/a | n/a | CN¥164m |
| Jun 30 2023 | n/a | n/a | CN¥164m |
| Mar 31 2023 | n/a | n/a | CN¥135m |
| Dec 31 2022 | CN¥1m | CN¥802k | CN¥106m |
| Sep 30 2022 | n/a | n/a | CN¥84m |
| Jun 30 2022 | n/a | n/a | CN¥63m |
| Mar 31 2022 | n/a | n/a | CN¥57m |
| Dec 31 2021 | CN¥1m | CN¥791k | CN¥52m |
| Sep 30 2021 | n/a | n/a | CN¥93m |
| Jun 30 2021 | n/a | n/a | CN¥133m |
| Mar 31 2021 | n/a | n/a | CN¥136m |
| Dec 31 2020 | CN¥1m | CN¥801k | CN¥139m |
| Sep 30 2020 | n/a | n/a | CN¥133m |
| Jun 30 2020 | n/a | n/a | CN¥128m |
| Mar 31 2020 | n/a | n/a | CN¥121m |
| Dec 31 2019 | CN¥986k | CN¥700k | CN¥115m |
| Sep 30 2019 | n/a | n/a | CN¥106m |
| Jun 30 2019 | n/a | n/a | CN¥97m |
| Mar 31 2019 | n/a | n/a | CN¥91m |
| Dec 31 2018 | CN¥603k | CN¥274k | CN¥85m |
Compensación vs. Mercado: Ying Feng($USD150.33K) está por debajo de la media de empresas de tamaño similar en el mercado Hong Kong ($USD235.82K).
Compensación vs. Ingresos: Ying Fengha sido coherente con los resultados de la empresa en el último año.
CEO
Ying Feng Lai (31 yo)
3.1yrs
Permanencia
CN¥1,081,000
Compensación
Mr. Ying Feng Lai has been Executive Director of Zhongzhi Pharmaceutical Holdings Ltd since May 14, 2018 and serves as its Chief Executive since March 24, 2021. Mr. Lai joined the Group since April 2014 an...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 9.3yrs | CN¥1.63m | 58.09% CN¥ 612.0m | |
| Chief Executive & Executive Director | 3.1yrs | CN¥1.08m | 0.69% CN¥ 7.3m | |
| CFO & Executive Director | 3.1yrs | CN¥837.00k | sin datos | |
| Deputy GM & Executive Director | 3.1yrs | CN¥1.19m | 0.38% CN¥ 4.0m | |
| Company Secretary | 6.9yrs | sin datos | sin datos |
3.1yrs
Permanencia media
41yo
Promedio de edad
Equipo directivo experimentado: 3737El equipo directivo de la empresa se considera experimentado (2.8 años de antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 9.3yrs | CN¥1.63m | 58.09% CN¥ 612.0m | |
| Chief Executive & Executive Director | 5.9yrs | CN¥1.08m | 0.69% CN¥ 7.3m | |
| CFO & Executive Director | 2.1yrs | CN¥837.00k | sin datos | |
| Deputy GM & Executive Director | 9.3yrs | CN¥1.19m | 0.38% CN¥ 4.0m | |
| Independent Non-Executive Director | 8.8yrs | CN¥154.00k | sin datos | |
| Non-Executive Director | 9.6yrs | CN¥269.00k | 4.89% CN¥ 51.5m | |
| Independent Non-Executive Director | 8.8yrs | CN¥154.00k | sin datos | |
| Independent Non-Executive Director | 8.8yrs | CN¥154.00k | sin datos | |
| Non-Executive Director | 2.3yrs | sin datos | sin datos |
8.8yrs
Permanencia media
55yo
Promedio de edad
Junta con experiencia: La junta directiva de 3737 se considera experimentada (8.5 años de antigüedad promedio).